These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1682543)

  • 1. Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone.
    Whitworth JA; Gilbert CE; Mabey DM; Maude GH; Morgan D; Taylor DW
    Lancet; 1991 Nov; 338(8775):1100-3. PubMed ID: 1682543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up.
    Mabey D; Whitworth JA; Eckstein M; Gilbert C; Maude G; Downham M
    Ophthalmology; 1996 Jul; 103(7):1001-8. PubMed ID: 8684787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining compliance to ivermectin in communities in two West African countries.
    Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
    Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual loss in an onchocerciasis endemic community in Sierra Leone.
    Whitworth JA; Gilbert CE; Mabey DM; Morgan D; Foster A
    Br J Ophthalmol; 1993 Jan; 77(1):30-2. PubMed ID: 8435395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses.
    Chippaux JP; Boussinesq M; Fobi G; Lafleur C; Audugé A; Banos MT; Ngosso A; Prod'hon J
    Ophthalmic Epidemiol; 1999 Dec; 6(4):229-46. PubMed ID: 10544338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
    Abiose A; Jones BR; Cousens SN; Murdoch I; Cassels-Brown A; Babalola OE; Alexander ND; Nuhu I; Evans J; Ibrahim UF
    Lancet; 1993 Jan; 341(8838):130-4. PubMed ID: 8093742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.
    Dadzie KY; Awadzi K; Bird AC; Schulz-Key H
    Trop Med Parasitol; 1989 Sep; 40(3):355-60. PubMed ID: 2694314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals.
    Whitworth JA; Morgan D; Maude GH; Luty AJ; Taylor DW
    Trans R Soc Trop Med Hyg; 1992; 86(3):277-80. PubMed ID: 1412652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.
    Dadzie KY; Remme J; Alley ES; de Sole G
    Trans R Soc Trop Med Hyg; 1990; 84(1):103-8. PubMed ID: 2345906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.
    Van der Lelij A; Rothova A; Klaassen-Broekema N; Wilson WR; Barbe RF; Stilma JS
    Doc Ophthalmol; 1990 Oct; 75(3-4):215-24. PubMed ID: 2090395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
    Dadzie KY; Remme J; De Sole G
    Trans R Soc Trop Med Hyg; 1991; 85(2):267-71. PubMed ID: 1887490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic side effects following ivermectin treatment in onchocerciasis patients from Sierra Leone.
    Stilma JS; Rothova A; van der Lelij G; Wilson WR; Barbe RF
    Acta Leiden; 1990; 59(1-2):207-10. PubMed ID: 2378206
    [No Abstract]   [Full Text] [Related]  

  • 13. Ivermectin treatment of patients with severe ocular onchocerciasis.
    Taylor HR; Semba RD; Newland HS; Keyvan-Larijani E; White A; Dukuly Z; Greene BM
    Am J Trop Med Hyg; 1989 May; 40(5):494-500. PubMed ID: 2658637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin treatment of ocular onchocerciasis.
    Taylor HR
    Acta Leiden; 1990; 59(1-2):201-6. PubMed ID: 2198751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin.
    Rothova A; Van der Lelij A; Stilma JS; Klaassen-Broekema N; Wilson WR; Barbe RF
    Am J Ophthalmol; 1990 Jul; 110(1):6-16. PubMed ID: 2368822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.
    Greene BM; Dukuly ZD; Muñoz B; White AT; Pacqué M; Taylor HR
    J Infect Dis; 1991 Feb; 163(2):376-80. PubMed ID: 1988521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to the initial dose.
    Whitworth JA; Morgan D; Maude GH; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1991; 85(1):92-6. PubMed ID: 2068774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocercal eye disease and the impact of Mectizan treatment.
    Abiose A
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds.
    Whitworth JA; Morgan D; Maude GH; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1991; 85(4):501-5. PubMed ID: 1755059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onchocerciasis in Sierra Leone 3: Relationships between eye lesions and microfilarial prevalence and intensity.
    McMahon JE; Sowa SI; Maude GH; Kirkwood BR
    Trans R Soc Trop Med Hyg; 1988; 82(4):601-5. PubMed ID: 3256114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.